Warehouse Overstock Promotion |  Save 10%  on Premium Lab Supplies |  Shop Now

Menu

This product has been added to the cart.

KCTD16 Polyclonal Antibody Reactivity Mouse

SKU: E-AB-52282-200

  • $ 55995
  • Save $ 4000


Request a Quote

KCTD16 Polyclonal Antibody Reactivity Mouse

 

SKU # E-AB-52282
Reactivity Human, Mouse
Host Rabbit
Applications WB, IHC

 

Product Details

Isotype IgG
Host Rabbit
Reactivity Human,  Mouse
Applications WB,  IHC
Clonality Polyclonal
Immunogen Fusion protein of human KCTD16
Abbre KCTD16
Synonyms BTB/POZ domain containing protein KCTD16,  BTB/POZ domain-containing protein KCTD16,  DKFZp781A1155,  KCD16,  KCTD16,  KIAA1317,  MGC138167,  Potassium,  Potassium channel tetramerisation domain containing 16,  Potassium channel tetramerization domain containing protein 16
Swissprot
Calculated MW 49 kDa
Observed MW Refer to figures
Cellular Localization Cell junction>synapse>presynaptic cell membrane. Cell junction>synapse>postsynaptic cell membrane.
Concentration 0.8 mg/mL
Buffer Phosphate buffered solution, pH 7.4, containing 0.05% stabilizer and 50% glycerol.
Purification Method Antigen affinity purification
Conjugation Unconjugated
Storage Store at -20°C Valid for 12 months. Avoid freeze / thaw cycles.
Shipping The product is shipped with ice pack, upon receipt, store it immediately at the temperature recommended.

 

Related Reagents

Applications Recommended Dilution
WB 1:500-1:2000
IHC 1:25-1:100

 

Background

The BTB (Broad-Complex, Tramtrack and Bric a brac) domain, also known as the POZ (Poxvirus and Zinc finger) domain, is an N-terminal homodimerization domain that contains multiple copies of kelch repeats and/or C2H2-type zinc fingers. Proteins that contain BTB domains are thought to be involved in transcriptional regulation via control of chromatin structure and function. KCTD16 (potassium channel tetramerisation domain containing 16), also known as BTB/POZ domain-containing protein KCTD16, is a 428 amino acid protein that contains one BTB (POZ) domain. An auxiliary subunit of GABAB R1 and GABAB R2, KCTD16 increases agonist potency and alters the G-protein signaling of the receptors by accelerating onset and promoting desensitization.